المؤلفون: Odler, B., Bikov, A., Streizig, J., Balogh, C., Kiss, E., Vincze, K., Barta, I., Horváth, I., Müller, V.

المصدر: Odler , B , Bikov , A , Streizig , J , Balogh , C , Kiss , E , Vincze , K , Barta , I , Horváth , I & Müller , V 2017 , ' CCL21 and IP-10 as blood biomarkers for pulmonary involvement in systemic lupus erythematosus patients ' , Lupus , vol. 26 , no. 6 , pp. 572-579 . https://doi.org/10.1177/0961203316668418Test

مصطلحات موضوعية: CCL21, diffusion capacity, immunoassay, IP-10, lung function, Systemic lupus erythematosus, carbon monoxide, CCL28 chemokine, chemokine, CXCL11 chemokine, gamma interferon inducible protein 10, interleukin 12p70, interleukin 17, monocyte chemotactic protein 4, secondary lymphoid tissue chemokine, unclassified drug, biological marker, CCL2 protein, human, CXCL10 protein, monocyte chemotactic protein 1, adolescent, adult, aged, Article, body mass, bronchiectasis, clinical article, comparative study, controlled study

الإتاحة: https://doi.org/10.1177/0961203316668418Test
https://research.manchester.ac.uk/en/publications/61555bac-22c1-4ece-a467-0078df33f7dfTest
http://real.mtak.hu/40546/1/Odler_Lupus2016.pdfTest

المؤلفون: Andras Bikov, Balazs Odler, J Streizig, Krisztina Vincze, Ildiko Horvath, C Balogh, Veronika Müller, Emese Kiss, I Barta

المصدر: Odler, B, Bikov, A, Streizig, J, Balogh, C, Kiss, E, Vincze, K, Barta, I, Horváth, I & Müller, V 2017, ' CCL21 and IP-10 as blood biomarkers for pulmonary involvement in systemic lupus erythematosus patients ', Lupus, vol. 26, no. 6, pp. 572-579 . https://doi.org/10.1177/0961203316668418Test

مصطلحات موضوعية: diffusion capacity, Lung Diseases, Male, 0301 basic medicine, gamma interferon inducible protein 10, lung disease, Vital capacity, CXCL10 protein, human, bronchiectasis, limit of quantitation, Gastroenterology, Pulmonary function testing, immunology, 0302 clinical medicine, systemic lupus erythematosus, DLCO, CXCL11 chemokine, Forced Expiratory Volume, middle aged, Lupus Erythematosus, Systemic, Lung volumes, interleukin 12p70, skin and connective tissue diseases, comparative study, pathophysiology, Chemokine CCL2, interstitial lung disease, clinical article, adult, Interstitial lung disease, Middle Aged, respiratory system, biological marker, unclassified drug, Respiratory Function Tests, Up-Regulation, aged, emphysema, female, priority journal, monocyte chemotactic protein 4, young adult, Female, lung volume, monocyte chemotactic protein 1, lung diffusion capacity, Adult, medicine.medical_specialty, lung function test, complication, IP-10, CCL28 chemokine, carbon monoxide, Article, smoking, 03 medical and health sciences, FEV1/FVC ratio, Rheumatology, forced vital capacity, blood, Internal medicine, medicine, cross-sectional study, Humans, controlled study, immunoassay, human, 030203 arthritis & rheumatology, Bronchiectasis, secondary lymphoid tissue chemokine, business.industry, chemokine, high risk population, Total Lung Capacity, lung function, medicine.disease, body mass, Chemokine CXCL10, Cross-Sectional Studies, 030104 developmental biology, sensitivity and specificity, adolescent, CCL2 protein, human, Immunology, microarray analysis, interleukin 17, business, Complication, upregulation, Biomarkers, CCL21

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d88d5121fc9407494a205ccc8031d85Test
https://doi.org/10.1177/0961203316668418Test